STEMSATION™ EXPANDS
PRODUCT LINE WITH SECOND PRODUCT
PROSTEM
PSP™
Second
Product Offering Poised to Generate
Significantly
more Revenue in
3rd Quarter
BOCA RATON, FL -- April 23,
2020 -- InvestorsHub NewsWire -- StemSation International, Inc. (OTC
Pink: STSN) – a pioneer in the emerging category of dietary
supplements called Stem Cell Nutrition, announces its second
product, a fast-acting and
exclusive formula named ProStem PSP™ for joint and muscle health
(https://www.stemsation.global/www/en/us/item/10016/ProStem-PSP-ProStem-PSP/).
ProStem
PSP is currently in
production. Sales are expected to
commence in the
3rd
quarter
of 2020, significantly
increasing
Revenues as
consumers continue to
take more personal
responsibility
for their
health and wellness during these unprecedented times.
The
market for
the
joint,
muscle, and bone health product
category
remains
strong with excellent potential
for growth. The market has consistently
grown over the last
several
years
and is expecting
to exceed
more than
US $3.3
billion
by 2024
at a CAGR of 6.5% in
the given forecast period, as reported by MarketWatch
Oct. 16, 2019 (https://www.marketwatch.com/press-release/bone-and-joint-health-ingredients-market-2019-set-for-rapid-growth-during-by-2024---market-research-engine-2019-10-16).
Developed
by Dr. Mira Gadzala, a highly respected PhD and
board-certified Alternative Medical
Practitioner, this
innovative product
utilizes the most recent research advancements of all-natural
ingredients and a new delivery system
to create
a
fast-acting,
highly
bioavailable,
safe, and
powerful formula like no
other. Dr. Gadzala is
StemSation's Chief
Scientific
Officer.
All ingredients in ProStem PSP are backed by
strong science, have been extensively studied, and clinically
proven for efficacy and safety. They come from organic, non-GMO,
and non-irradiated natural sources found in nature. ProStem
PSP does not contain any
fillers, chemicals, heavy metals, contaminants, synthetic
preservatives, colors, or additives.
Dr. Mira
Gadzala commented,
"We are excited to
offer
our
second innovative,
fast-acting, and exceptional quality
natural product that
supports
joint and muscle
health
in a multidimensional
way.
ProStem
PSP
provides
a
novel
combination of highly effective
and clinically proven
nutrients
and delivery system
that
helps
to
form
a
strong
and long-lasting foundation for joint and
muscle
health,
natural nourishment
and repair,
collagen
structure,
and flexibility. The
highly potent
antioxidants
and other natural compounds
in
ProStem
PSP
also support the
cellular
energy processes, and circulatory
and
immune system responses
that are
pivotal
aspects
in joint
and
muscle
health and allows the body to
function on more optimum and healthy level.
"
Bone health has become a major public health
concern across the globe. According
to statistics, about 75
million people in the United States, Europe,
and Japan
have
bone
health concerns, and the population with bone and joint health
issues is growing
at alarming rates,
as more baby boomers enter their
60's and early 70's globally.
Joint health used to predominantly
be associated with older people,
but not anymore.
Baby boomers
of today,
as well as younger generations,
are concerned about their
physical
fitness,
mobility, and
joint and muscle health.
StemSation
is a company
with a long-term 'health
mission', ambitious research goals, and innovative,
holistic
approaches to health &
wellness, and healthy longevity. Our product line shows a new
pathway to
wellness.
ABOUT
DR. MIRA GADZALA
Dr.
Mira
Gadzala
has
three decades
of
experience
in formulating natural dietary supplement
products, and is the
founder
of BioCell
Rejuvenation™,
a consulting, research and development company in the field of
alternative
health and vitamins.
Her most recent work involves researching
and formulating
advanced
stem cell nutrition products. Dr. Gadzala holds a PhD degree
in Holistic Nutrition, a
Master of Sciences
(MSc) in Cell Biology and
pursued a
doctoral degree in Cell Biology.
She has been granted a full Board Certification as an
Alternative
Medical
Practitioner (AMP) by the American Alternative Medical
Association
and holds two prestigious
designations:
Registered Orthomolecular Health Practitioner (ROHP) and
Registered
Nutritional Consultant
Practitioner (RNCP). Dr. Gadzala is a
member
of several
health
organizations, including the American Alternative Medical
Association and International
Organization of
Nutritional Consultants (Canada, USA), and has served on the
Advisory
Board of
the "Cellular Health Communication" magazine
(US),
Stemtech's
Scientific
Advisory
Board,
and as a primary member
of the Institutional Animal Care and Use
Committee (IACUC) at a
California-based vitamin research company.
ABOUT
STEMSATION
INTERNATIONAL,
INC.
StemSation
International, Inc. (OTC
"STSN")
develops,
manufactures
and distributes natural
wellness products that support the stem cell and
endocannabinoid systems
in the human body through
using
a direct selling model in which Independent
Wellness
Advocates ("IWAs") advertise and sell its products
directly
to consumers.
StemSation
is headquartered in Boca Raton, Florida and
its
website
can be
located at
www.stemsation.global.
SAFE
HARBOR STATEMENT
This
press release contains forward-looking statements
that
can be identified
by terminology such as "believes," "expects," "potential," "plans,"
"suggests,"
"may," "should,"
"could," "intends," or similar expressions. Many forward-looking
statements involve
known and unknown risks, uncertainties and other
factors
that may
cause
actual
results to be materially different from any future results
implied by
such statements. These
factors include, but are not limited to, our ability to continue to
enhance our
products
and systems to address industry changes, our
ability
to expand
our
customer
base and retain existing customers, our ability to effectively
compete
in our market segment,
the lack of public information on our company, our ability to raise
sufficient
capital
to fund our business, operations, our ability
to continue
as
a going
concern, and a limited public market for our common stock, among
other risks.
Many factors are difficult
to predict accurately and are generally beyond the company's
control.
Forward-looking
statements speak only as to the date they
are
made,
and
we do
not
undertake to update forward-looking statements to reflect
circumstances
or events that occur after
the date the forward-looking statements are made.
FOR
INFORMATION,
PLEASE
CONTACT:
Nicholas
B. Panza, Vice-President
Stemsation
International,
Inc.
7777
Glades
Road
Suite
203
Boca
Raton, FL
33434
npanza@stemsationusa.com
(561)
245-7454